Literature DB >> 2430342

A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes.

H C Hemker, G M Willems, S Béguin.   

Abstract

A method is described that, on the basis of the time course of amidolytic activity after the triggering of thrombin generation in normal plasma, allows the calculation of the velocity of prothrombin conversion independent of thrombin inactivating processes. It is shown how the reaction constants for the alpha 2M-dependent and the alpha 2M-independent thrombin inactivation processes can be obtained in a sample of whole plasma. The method is verified by demonstrating that the experimentally observed time courses of residual prothrombin and of alpha 2M-thrombin complex coincide with those calculated from the time course of amidolytic activity, and by showing that the course of prothrombin conversion in plasma without alpha 2-macroglobulin or AT III is adequately described if the alpha 2M or AT III-dependent breakdown constants are taken zero in the calculations. It appears that the inactivation of thrombin, endogenously generated in whole plasma, is about half as fast as that of exogenous thrombin added to the plasma. A computer program is presented that carries out the relevant calculations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430342

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  22 in total

1.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Authors:  J C Reverter; S Béguin; H Kessels; R Kumar; H C Hemker; B S Coller
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Protein S modulates the anticoagulant action of recombinant human activated protein C: a comparison between neonates and adults.

Authors:  Gerhard Cvirn; Martin Koestenberger; Bettina Leschnik; Christoph Male; Joerg Kutschera; Ulrika Ferstl; Wolfgang Muntean; Guenther Juergens; Siegfried Gallistl
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

3.  Comparison of biological activities of two low molecular weight heparins in 10 healthy volunteers.

Authors:  M Azizi; C Veyssier-Belot; M Alhenc-Gelas; G Chatellier; E Billaud-Mesguish; J N Fiessinger; M Aiach
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

4.  In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices.

Authors:  Gaurav Girdhar; Junwei Li; Larisa Kostousov; John Wainwright; Wayne L Chandler
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

5.  Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.

Authors:  C Aparicio; B Dahlbäck
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

6.  A mathematical model of thrombin production in blood coagulation, Part I: The sparsely covered membrane case.

Authors:  S A Baldwin; D Basmadjian
Journal:  Ann Biomed Eng       Date:  1994 Jul-Aug       Impact factor: 3.934

Review 7.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

8.  Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?

Authors:  Brian Dale; John W Eikelboom; Jeffrey I Weitz; Ed Young; Jeremy S Paikin; Michiel Coppens; Richard P Whitlock; Stuart J Connolly; Jeffrey S Ginsberg; Jack Hirsh
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

9.  Generation of thrombin activity in relation to factor VIII:C concentrations and vascular complications in type 1 (insulin-dependent) diabetes mellitus.

Authors:  S H Ibbotson; D Walmsley; J A Davies; P J Grant
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

10.  Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay.

Authors:  Veronique Ollivier; Jianguo Wang; David Manly; Kellie R Machlus; Alisa S Wolberg; Martine Jandrot-Perrus; Nigel Mackman
Journal:  Thromb Res       Date:  2009-04-05       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.